Full Text View
Tabular View
No Study Results Posted
Related Studies
Ferric Citrate in Patients With End-Stage Renal Disease on Dialysis
This study has been completed.
Study NCT01510106   Information provided by University of Pennsylvania

First Received on January 10, 2012.   Last Updated on March 14, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
ESRD
Dialysis
Hyperphosphatemia
Additional conditions recognized in this trial
Kidney Diseases
Kidney Failure, Chronic
More general conditions related to this trial
Metabolic Diseases
Phosphorus Metabolism Disorders
Renal Insufficiency
Renal Insufficiency, Chronic
Urologic Diseases
Interventions listed in this trial
Ferric citrate
Additional drug interventions recognized in this trial
Calcium acetate
Citric Acid
Sevelamer
More general drug interventions related to this trial
Anticoagulants
Chelating Agents
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
University of Pennsylvania
Keryx Biopharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services